| 1. Karoly K, Sandor E, Edit S, Miklos F, Judit S, Benjamin P, Andrea S, Istvan H. (1997) Prolyl endopeptidase inhibitors1: N-acyl derivatives of L-thioproline-pyrrolidine, 7 (13): [10.1016/S0960-894X(97)00295-3] |
| 2. Tanaka Y, Niwa S, Nishioka H, Yamanaka T, Torizuka M, Yoshinaga K, Kobayashi N, Ikeda Y, Arai H.. (1994) New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues., 37 (13): [PMID:8027988] [10.1021/jm00039a019] |
| 3. Portevin B, Benoist A, Rémond G, Hervé Y, Vincent M, Lepagnol J, De Nanteuil G.. (1996) New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives., 39 (12): [PMID:8691432] [10.1021/jm950858c] |
| 4. Vendeville S, Bourel L, Davioud-Charvet E, Grellier P, Deprez B, Sergheraert C.. (1999) Automated parallel synthesis of a tetrahydroisoquinolin-based library: potential prolyl endopeptidase inhibitors., 9 (3): [PMID:10091698] [10.1016/s0960-894x(99)00003-7] |
| 5. Wallén EA, Christiaans JA, Forsberg MM, Venäläinen JI, Männistö PT, Gynther J.. (2002) Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors., 45 (20): [PMID:12238937] [10.1021/jm020966g] |
| 6. Jarho EM, Venäläinen JI, Huuskonen J, Christiaans JA, Garcia-Horsman JA, Forsberg MM, Järvinen T, Gynther J, Männistö PT, Wallén EA.. (2004) A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors., 47 (23): [PMID:15509157] [10.1021/jm049503w] |
| 7. Jarho EM, Wallén EA, Christiaans JA, Forsberg MM, Venäläinen JI, Männistö PT, Gynther J, Poso A.. (2005) Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions., 48 (15): [PMID:16033257] [10.1021/jm0500020] |
| 8. Jarho EM, Venäläinen JI, Juntunen J, Yli-Kokko AL, Vepsäläinen J, Christiaans JA, Forsberg MM, Järvinen T, Männistö PT, Wallén EA.. (2006) An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitors., 16 (21): [PMID:16919454] [10.1016/j.bmcl.2006.08.029] |
| 9. Kánai K, Arányi P, Böcskei Z, Ferenczy G, Harmat V, Simon K, Bátori S, Náray-Szabo G, Hermecz I.. (2008) Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules., 51 (23): [PMID:19006380] [10.1021/jm800944x] |
| 10. Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N.. (2010) Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors., 53 (9): [PMID:20058865] [10.1021/jm901104g] |
| 11. Van der Veken P, Fülöp V, Rea D, Gerard M, Van Elzen R, Joossens J, Cheng JD, Baekelandt V, De Meester I, Lambeir AM, Augustyns K.. (2012) P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy., 55 (22): [PMID:23121075] [10.1021/jm301060g] |
| 12. Kallinen A, Todorov B, Kallionpää R, Bäck S, Sarparanta M, Raki M, García-Horsman JA, Bergström KA, Wallén EA, Männistö PT, Airaksinen AJ.. (2014) Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo., 79 [PMID:24763264] [10.1016/j.ejmech.2014.04.014] |
| 13. Kilpeläinen TP, Tyni JK, Lahtela-Kakkonen MK, Eteläinen TS, Myöhänen TT, Wallén EAA.. (2019) Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors., 10 (12): [PMID:31857839] [10.1021/acsmedchemlett.9b00394] |
